^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    XKDCT080

    i
    Associations
    News
    Trials
    Company:
    Celconta Group, First Condor Biotech
    Drug class:
    GUCY2C-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials